Stifel Nicolaus initiated coverage on shares of Haleon (NYSE:HLN – Get Rating) in a research note issued to investors on Wednesday morning, The Fly reports. The firm issued a hold rating on the stock.
Other equities analysts also recently issued reports about the stock. Investec started coverage on shares of Haleon in a report on Thursday, February 23rd. They set a sell rating on the stock. Barclays upped their price target on shares of Haleon from GBX 360 ($4.48) to GBX 364 ($4.53) in a report on Tuesday, January 31st. Argus upgraded shares of Haleon from a hold rating to a buy rating in a report on Thursday, April 6th. Finally, Sanford C. Bernstein started coverage on shares of Haleon in a report on Tuesday, April 4th. They set an outperform rating on the stock. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of Hold and an average target price of $364.00.
Haleon Price Performance
Shares of NYSE HLN opened at $8.32 on Wednesday. Haleon has a 12-month low of $5.59 and a 12-month high of $9.05. The firm’s 50-day moving average price is $8.59 and its 200-day moving average price is $7.98. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.62 and a current ratio of 0.93.
Haleon Dividend Announcement
Institutional Investors Weigh In On Haleon
Hedge funds and other institutional investors have recently bought and sold shares of the company. City State Bank purchased a new stake in Haleon during the first quarter valued at approximately $25,000. CKW Financial Group acquired a new stake in shares of Haleon in the third quarter worth $26,000. CoreFirst Bank & Trust acquired a new stake in Haleon during the fourth quarter valued at $26,000. Ahrens Investment Partners LLC acquired a new stake in Haleon during the first quarter valued at $27,000. Finally, GW&K Investment Management LLC grew its position in Haleon by 308.4% during the first quarter. GW&K Investment Management LLC now owns 3,529 shares of the company’s stock valued at $29,000 after buying an additional 2,665 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
- Get a free copy of the StockNews.com research report on Haleon (HLN)
- Toll Brothers Rises On Results, But The Roof Is In Place
- It’s Time To Try On VF Corporation’s 6% Yield
- PetCo Management Getting it Right? Earnings Beat Says Yes
- Axcelis Stock In Buy Range After Chart Breakout, Strong Guidance
- Kohl’s 10% Yield Comes Into High Fashion
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.